Background {#Sec1}
==========

Corneal opacity and cataract are the primary causes of decreased visual acuity. There are two currently surgical treatments options for patients with corneal opacity and cataract. The Triple procedure, simultaneous penetrating keratoplasty (PK), cataract extraction and intraocular lens (IOL) implantation provides a shorter visual rehabilitation period \[[@CR1]\]. However, the disadvantages include risk of expulsive hemorrhage, inadequate cortical cleaning and inaccuracy in IOL power calculation can decrease postoperative visual acuity \[[@CR2]\]. Cataract surgery without PK is sometimes associated with good visual acuity when the corneal opacity partially obscures the pupillary area \[[@CR3]\]. Even though visual outcomes after cataract surgery in eyes with corneal opacities can vary, corneal opacity severity may be one of the major prognostic factors of visual acuity \[[@CR4]\]. When there is opacity in the patient's cornea, astigmatism usually occurs in the vertical axis (with-the-rule astigmatism), horizontal axis (against-the-rule astigmatism), oblique axis, or irregular axis. When the patient's cornea has regular astigmatism, good visual acuity can be achieved through astigmatic correction. During cataract surgery, astigmatism can be corrected by prescription glasses, contact lenses, corneal relaxing incisions, astigmatic keratotomy, limbal relaxing incisions, excimer laser ablation, or toric IOL implantation \[[@CR5]\]. Toric IOL implantation is the most reliable and effective method for correcting regular astigmatism during cataract surgery. We hypothesized that toric IOL implantation can improve visual acuity in patients with corneal opacity and regular corneal astigmatism.

To the best of our knowledge, there are currently no studies that have evaluated the efficacy of toric IOL implantation in cataract patients with corneal opacity.

Methods {#Sec2}
=======

This study was conducted by performing a retrospective chart review and data analysis. This study was conducted in compliance with Institutional Review Board regulations.

Patients {#Sec3}
--------

Thirty-one patients that had cataract and corneal opacity with regular astigmatism were enrolled from Bucheon St. Mary's Hospital from June 2017 to April 2018.

Inclusion criteria were corneal opacification that involved the visual axis and advanced cataract in patients with corneal astigmatism over 1.5 Diopter and eyes with partially visible anterior capsules and pupillary margins. Patients with a history of any ocular injury or disorder, infection, inflammation, surgery within the prior 6 months and an eye with irregular astigmatism such as keratoconus and keratoectasia were excluded.

Preoperative evaluation {#Sec4}
-----------------------

All patients underwent a complete preoperative ophthalmological examination. The demographic and perioperative data were recorded. Uncorrected and corrected distance visual acuity were expressed as logMAR. Manifest refraction, biometry and keratometry with the IOLMaster partial coherence interferometry device (Carl Zeiss Meditec AG), corneal topography to exclude irregular astigmatism, slit lamp examination, and dilated funduscopy were performed. The total corneal astigmatism was measured using the Scheimpflug system (Pentacam®, Oculus, Germany). The preoperative astigmatism was examined repeatedly three times using multiple devices. The IOL manufacturer's web-based toric calculator was used to determine the required cylinder power and axis for implantation. We undercorrected the diopters of toric IOLs rather than overcorrection based on preoperative total corneal astigmatism. The size of corneal opacity covering pupillary area was measured as (vertical + horizontal opacity covering pupil/2) with undilated pupil using image J (National Institutes of Health, Maryland) (Fig. [1](#Fig1){ref-type="fig"}). The spherical power of the IOL was chosen on the basis of keratometric values and axial length measurement using the IOLMaster and the SRK/T (Sanders-Retzlaff-Kraff/Theoretical) formula. The astigmatic power of toric IOL was calculated with the online TECNIS calculators, and surgically induced astigmatism was designated as 0.5 D. The corneal steep axis and astigmatism amount were determined using keratometry with the IOLMaster and 3 mm of the total corneal astigmatism map in the Scheimpflug system. Therefore, lenticular astigmatism of patient was not included as an amount of astigmatism correction using toric IOL. Fig. 1How to measure the size of corneal opacity covering pupil using image J. The vertical opacity was 2.9 mm and horizontal opacity was 3.6 mm, so the size of corneal opacity covering pupil is (2.9 + 3.6)/2 = 3.25 mm

Operative procedures {#Sec5}
--------------------

Before surgery, the corneal limbus was marked at the 0^∘^, 90^∘^, and 180^∘^ meridians with the patient in a sitting position after instilling topical anesthetic eye drops. All operations were performed under topical anesthesia by a single skilled surgeon (E.C.K) using the Intrepid Infiniti system (Alcon Laboratories, Inc., Fort Worth, TX, USA). The corneal steep axis and 6.0 mm ring were marked with gentian violet. Surgery was performed through a clear corneal incision at the steep astigmatic axis. After topical ocular anesthesia was applied, a 2.75 mm clear corneal incision was made using a 2.75 mm double-blade keratome (Alcon). Sodium hyaluronate 1.0% (Hyal Plus, LG Life Science, Seoul, Korea) was used to reform and stabilize the anterior chamber. A continuous curvilinear capsulotomy was made with a 6.0 mm corneal marker using Inamura capsulorhexis forceps (Duckworth & Kent Ltd., Baldock, UK). Hydrodissection and hydrodelineation were achieved using a balanced salt solution. Phacoemulsification was performed using 2.75-mm-sized phaco-tips and infusion/aspiration (I/A) cannulas in the micro- and small-incision groups, respectively. A clear preloaded IOL (Tecnis ZCT; Abbott Medical Optics) was implanted in the capsular bag. Toric markings of IOLs are located under marking of corneal steep axis using retroillumination of operative microscope. The wound was not sutured (Video). Postoperative treatment consisted of gatifloxacin 0.3% (Gatiflo, Handok, Chungbuk, Korea) and fluorometholone acetate 0.01% (Ocumetholone, Samil, Seoul, Korea) eye drops four times a day for 4 weeks.

**Additional file 1: Video.** Implantation of Toric Intraocular Lens in Patient with Cataract and Corneal Opacity. Toric Intraocular Lens was implanted in patient with central corneal opacity.

Postoperative evaluation {#Sec6}
------------------------

After 2 months later, uncorrected and corrected distance visual acuity, manifest refraction, and residual refractive astigmatism were measured. The axis of toric IOL was measured with PicPickTools (NGWIN, Seoul, Korea) using photography of anterior segment under pupil dilation at postoperative 1 day and 2 months. Axis rotation of toric IOL was calculated using the difference of axis between postoperative 1 day and 2 months.

Statistical analysis {#Sec7}
--------------------

Statistical analysis was performed using a commercial program (SPSS for Windows; version 21.0.1; SPSS Inc., Chicago, IL). The Wilcoxon signed rank test was used to compare pre- and postoperative BCVA and refractive and keratometry astigmatism. *P* values \< 0.05 were considered statistically significant.

Results {#Sec8}
=======

Thirty-one eyes of 31 patients were enrolled in the study. Table [1](#Tab1){ref-type="table"} summarizes the patient demographics and the preoperative data. The preoperative diagnoses comprised trichiasis, corneal ulcer, herpes keratitis, previous pterygium surgery, uveitis, traumatic corneal scar, and unknown (Table [2](#Tab2){ref-type="table"}). Postoperative UCVA (0.30 ± 0.17) and BCVA (0.22 ± 0.16) were significantly improved compared to preoperative UCVA (1.20 ± 0.34) and BCVA (1.10 ± 0.30) (*P* \< 0.05) (Fig. [2](#Fig2){ref-type="fig"}). The UCVA 2 months postoperatively was 20/32 or better in 19 eyes (61.3%) and 20/25 or better in 7 eyes (22.6%) (Fig. [3](#Fig3){ref-type="fig"}). The postoperative residual refractive astigmatism (1.20 ± 0.35 D) was significantly reduced compared to preoperative refractive astigmatism (2.4 ± 0.65 D) (*P* \< 0.05). Preoperative and postoperative total corneal astigmatism (1.91 ± 0.44 & 1.52 ± 0.38 D, respectively) were not significantly different (Fig. [4](#Fig4){ref-type="fig"}). The percentage of patients with residual astigmatism within ±0.5D was 22.6% (7 eyes of 31), and that with residual astigmatism within ±1.0D was 60% (18 eyes of 31) (Fig. [5](#Fig5){ref-type="fig"}). Table 1The patient demographics and the preoperative dataParametersTotal patients (Eyes)31 (31)Male: Women (ratio)14:17Patient age (years)57.44 ± 12.01Mean auto-refractive cylinder (Diopter)2.40 ± 0.65Mean total corneal astigmatism (D)1.91 ± 0.44Mean BCVA (logMAR)1.10 ± 0.30Data represent mean ± standard deviationTable 2The causes of corneal opacityNumber of eyesTrichiasis3Corneal ulcer5Herpes keratitis2Previous pterygium surgery3Uveitis5Traumatic corneal scar6Unknown7Total31Fig. 2Preoperative and 2 month postoperative visual acuity Values are presented as mean ± SD. UCVA: uncorrected visual acuity, BCVA: best corrected visual acuity, Postoperative UCVA (0.30 ± 0.17) and BCVA (0.22 ± 0.16) were significantly improved compared to preoperative UCVA (1.20 ± 0.34) and BCVA (1.10 ± 0.30) (*P* \< 0.05)Fig. 3Preoperative and 2 month postoperative visual acuity distribution, Values are presented as mean ± SD. UCVA: uncorrected visual acuity, The UCVA 2 months postoperatively was 20/32 or better in 19 eyes (61.3%) and 20/25 or better in 7 eyesFig. 4Preoperative and 2 month postoperative astigmatism, Values are presented as mean ± SD. D: Diopter, Postoperative residual refractive astigmatism (1.20 ± 0.35 D) was statistically reduced compared to preoperative refractive astigmatism (2.4 ± 0.65 D) (*P* \< 0.05)Fig. 5Preoperative and 2 month postoperative astigmatism distribution, Values are presented as mean ± SD. D: Diopter, The percentage of residual astigmatism within ±0.5D was 22.6% (7 eyes of 31) and within ±1.0D was 58.1% (27 eyes of 31)

100% cases achieved UCVA and BCVA were as good as or better than that preoperatively with correction. 42.9% cases achieved better UCVA compared to preoperative BCVA 0.5 logMAR over and 77.4% cases achieved better BCVA compared to preoperative BCVA 0.5 logMAR over (Fig. [6](#Fig6){ref-type="fig"}a and b). The size of corneal opacity covering pupil had significant positive correlation with postoperative UCVA and BCVA (logMAR) (*R* = 0.91 *P* \< 0.05 and *R* = 0.92 *P* \< 0.05, respectively) (Fig. [7](#Fig7){ref-type="fig"}). The size of corneal opacity covering pupil had significant positive correlation with and preoperative attempted correction -- postoperative corrected astigmatism (D) (*R* = 0.94, *P* \< 0.05) (Fig. [8](#Fig8){ref-type="fig"}). Axis rotation of the TIOL between postoperative 1 day and 2 months after cataract surgery was 3.25 ± 1.44 degrees. Achieved correction of astigmatism (preoperative -- postoperative refractive astigmatism) was significantly smaller than attempted correction of astigmatism (*P* \< 0.05) (Fig. [9](#Fig9){ref-type="fig"}). Fig. 6Comparison of preoperative BCVA and postoperative UCVA (**a**) & BCVA (**b**) in logMAR. Values are presented as mean ± SD. UCVA: Uncorrected visual acuity, BCVA: Best corrected visual acuity, 100% cases achieved UCVA and BCVA were as good as or better than that preoperatively with correctionFig. 7Correlation of the size of corneal opacity covering pupill and postoperative UCVA (**a**) and BCVA (**b**) (logMAR). UCVA: Uncorrected visual acuity, BCVA: Best corrected visual acuity, The size of corneal opacity covering pupil had significant positive correlation with postoperative UCVA and BCVA (logMAR) (*R* = 0.91 *P* \< 0.05 and *R* = 0.92 *P* \< 0.05, respectively)Fig. 8Correlation of the size of corneal opacity covering pupill and preoperative attempted correction -- postoperative corrected astigmatism (D). D: Diopter, The size of corneal opacity covering pupil had significant positive correlation with and preoperative attempted correction -- postoperative corrected astigmatism (D) (*R* = 0.94, *P* \< 0.05)Fig. 9Comparison of Achieved correction of astigmatism and attempted correction of astigmatism (D). Achieved correction of astigmatism (preoperative --postoperative refractive astigmatism) was significantly smaller than attempted correction of astigmatism (*P* \< 0.05)

The vector analysis are described in Table [3](#Tab3){ref-type="table"}. The target astigmatism (TA) was 1.75 ± 0.58 D, and the corrected astigmatism (CA) with toric IOLs was 1.23 ± 0.64 D. The angle of error between the axis of CA and TA was 2.19 ± 1.32 degrees, and the difference of vector (DV) was 0.95 ± 0.67 D. The astigmatism correction index (CA/TA) was 0.70, and the index of success (DV/TA) was 0.54. Table 3Vector analysis of toric IOLsParameterMean ± SDTarget astigmatism (TA) (D)1.75 ± 0.58Corrected astigmatism (CA) (D)1.23 ± 0.64Angle of error between the axis of CA and TA (degree)2.19 ± 1.32Difference of vector (DV) (D)0.95 ± 0.67Astigmatism correction index (CA /TA)0.70Index of success (DV/TA)0.54

Figure [10](#Fig10){ref-type="fig"} shows data from a 77-year-old male patient treated for bacterial keratitis in his right eye. His inferior temporal cornea was opaque and very thin (Fig. [10](#Fig10){ref-type="fig"}b) because of previous bacterial keratitis (Fig. [10](#Fig10){ref-type="fig"}a). His preoperative BCVA was 20/200 and refractive astigmatism was 2.5D. After a Tecnis ZCT225 was inserted, postoperative 2 month UCVA was 20/22, BCVA was 20/20, and residual refractive astigmatism was 1.0D. Figure [11](#Fig11){ref-type="fig"} involves a 63-year-old female patient who reported central corneal opacity in her right eye from birth. Her preoperative BCVA was 20/60 and refractive astigmatism was 2.75D. After a Tecnis ZCT300 was inserted, her postoperative 2 month UCVA was 20/24, BCVA was 20/22, and residual refractive astigmatism was 1.25D. Fig. 10Preoperative image of a patient treated for bacterial keratitis. Inferior temporal cornea is opaque and very thin (Fig. [7](#Fig7){ref-type="fig"}b) because of previous bacterial keratitis (Fig. [7](#Fig7){ref-type="fig"}a). The patient's preoperative UCVA, BCVA, and refractive astigmatism improved at 2 months postoperativelyFig. 11Preoperative image of a patient with congenital central corneal opacity. The patient's preoperative UCVA, BCVA, and refractive astigmatism were improved at 2 months postoperatively

Discussion {#Sec9}
==========

About 60% of patients with normal corneas that undergo cataract surgery have more than 0.75D of corneal astigmatism \[[@CR6]\]. Therefore, patients with cataract and corneal opacity have greater corneal astigmatism than the normal population \[[@CR7]\]. Consequently, simultaneous penetrating keratoplasty and cataract surgery may be the preferred treatment option in this patient group \[[@CR2], [@CR8]\]. However, simultaneous penetrating keratoplasty and cataract surgery may induce more astigmatism than the preoperative condition \[[@CR2], [@CR8]\]. Phacoemulsification and IOL implantation in selected cases of coexisting cataract and corneal opacity are safe and can provide suboptimal but long-term vision when penetrating keratoplasty is not an option or there is a high risk of graft failure \[[@CR4]\]. Cataract surgery with toric IOL implantation could better improve visual acuity than simultaneous penetrating keratoplasty and cataract surgery when the central cornea is not totally opaque \[[@CR3]\]. BCVA improvements after surgery are less likely for more severe opacity indices that involve the pupil, according to the reflectivity signal \[[@CR4]\].

In this study, postoperative UCVA (0.30 ± 0.17) and BCVA (0.22 ± 0.16) were significantly improved compared to preoperative UCVA (1.20 ± 0.34) and BCVA (1.10 ± 0.30) (*P* \< 0.05). Ho et al. reported preoperative mean UCVA and BCVA of 20/800 and 20/630, respectively, which significantly improved to 20/200 and 20/160 (*P* \< 0.001) after cataract surgery with monofocal IOL implantation in patients with corneal opacity \[[@CR4]\]. In the Ho et al.'s study, the amount of visual acuity improvement was less than that in our study, because astigmatism was not corrected in this study \[[@CR4]\].

Müftüoğlu İK reported that mean preoperative BCVA significantly increased (0.7 ± 0.3 \[range: 0.3--1.3\] logMAR to 0.1 ± 0.04 \[range: 0.05--0.15\] logMAR; *P* \< 0.05) at a mean of 8.71 ± 64.11 months after cataract surgery with toric IOL implantation in patients with cataract formation and high astigmatism after penetrating keratoplasty \[[@CR9]\]. Development of cataract is highly possible after PK because of chronic high-dose steroid use and surgical intervention. Toric IOLs are reported to be an effective modality to correct astigmatism in patients with cataract \[[@CR10]--[@CR12]\]. Additionally, visual acuity improvement was greater in the study by Müftüoğlu İK than in our study, because the corneas in their study were relatively clear after PK compared to those in our study.

In this study, the 2 month postoperative UCVA was 20/32 or better in 19 eyes (61.3%) and 20/25 or better in 7 eyes (22.6%). This indicates that the majority of patients who underwent toric IOL implantation will not need to wear glasses daily. The corrected distance Snellen visual acuity (with spectacles or contact lenses) 12 months postoperatively was 20/32 or better in 82% of eyes in keratoconus patients with toric IOL implantation \[[@CR13]\]. In the normal cataract patients that did not have corneal opacity, mean LogMAR UDVA and BDVA were 0.19 ± 0.12 and 0.14 ± 0.10, respectively. In addition, a postoperative UDVA of 20/40 or better was achieved in 92.6% of eyes \[[@CR14]\].

In this study, postoperative residual refractive astigmatism (1.20 ± 0.35 D) was significantly reduced compared to preoperative refractive astigmatism (2.4 ± 0.65 D) (*P* \< 0.05). Müftüoğlu İK reported that the mean preoperative corneal keratometric astigmatism was 5.4 ± 0.9 D (range: 4.25--7.00 D) at the corneal plane and 6.3 ± 1.0 D (range: 4.9--8.1 D) at the spectacle plane, and the average manifest refractive astigmatism was 1.5 ± 0.7 D (range: 0.25--2.25 D) at postoperative month 1 after toric IOL implantation in patients that had previously undergone penetrating keratoplasty \[[@CR9]\]. Postoperative refractive astigmatism significantly decreased in their study, which was in agreement with the results of our study. In contrast, refractive astigmatism persisted after cataract surgery with monofocal IOL implantation \[[@CR4]\]. In normal cataract patients without corneal opacity, mean refractive cylinder decreased significantly from − 3.73 ± 1.96 to − 1.42 ± 0.88D (푝 \< 0.001), while keratometric cylinder did not change significantly (P=0.44) after toric IOL implantation \[[@CR14]\]. The visual and refractive astigmatic outcomes inferior to normal cataract without corneal opacity, but improved even though there was corneal opacity in this study.

In another study, 92.3% cases achieved visual acuity were as good as or better than that preoperatively with correction after monofocal IOL implantation \[[@CR4]\]. However, in this study, all cases achieved postoperative visual acuity as good as or better than preoperative one after toric IOL implantation.

In central corneal opacity, phacoemulsification should be performed when the extent of opacity is small enough to improve visual acuity after surgery \[[@CR15]\]. In this study, we included patients with peripheral corneal opacity as demonstrated in Fig. [10](#Fig10){ref-type="fig"}, and large central corneal opacity as in Fig. [11](#Fig11){ref-type="fig"}. Patient with peripheral corneal opacity had more improved postoperative UCVA and BCVA compared to patient with central corneal opacity, in these cases. Regarding visual outcome, Ho Y. et al. reported that there is no significant correlation between logMAR BCVA and corneal densitometry and OCT grading (*P* \> 0.05) \[[@CR4]\]. However, in this study, the size of corneal opacity covering pupil had significant negative correlation with postoperative UCVA and BCVA (logMAR) (*R* = 0.91 *P* \< 0.05 and *R* = 0.92 *P* \< 0.05, respectively) (Fig. [7](#Fig7){ref-type="fig"}). The size of corneal opacity covering pupil had significant positive correlation with and preoperative attempted correction -- postoperative corrected astigmatism (D) (*R* = 0.94, *P* \< 0.05) (Fig. [8](#Fig8){ref-type="fig"}). The patients with central corneal opacity had poor visual outcome and astigmatic correction because the opacity occurred in early childhood, the central light cannot passed to the retina properly, and the patients had relatively irregular corneal astigmatism compared to patients with peripheral corneal opacity."

In this study, achieved correction of astigmatism (preoperative --postoperative refractive astigmatism) was significantly smaller than attempted correction of astigmatism (*P* \< 0.05) (Fig. [9](#Fig9){ref-type="fig"}). The correction of astigmatism using toric IOL was inaccurate compared to normal patients with clear cornea, because corneal opacity might inhibit precise measurement of preoperative total corneal astigmatism.

The corneal astigmatism associated with corneal opacity should not be considered same as regular corneal astigmatism for the selection of toric IOL. Toric IOL can be undercorrected (Fig. [9](#Fig9){ref-type="fig"}) because of relatively skewed deviation of axis and uneven surface of cornea.

Therefore, we concluded that not the central corneal opacity size, but the size of corneal opacity covering pupil was the major prognostic factor for postoperative visual improvement. Patients with paracentral corneal opacity are the best candidates for cataract surgery to optimize vision \[[@CR15]\]. But, if corneal opacity did not cover the whole central pupillary area, good vision can be achieved with cataract surgery and toric IOL implantation.

In the vector analysis, the target astigmatism (TA) was 1.75 ± 0.58 D, and the corrected astigmatism (CA) with toric IOLs was 1.23 ± 0.64 D. The angle of error between the axis of CA and TA was 2.19 ± 1.32 degrees, and the difference of vector (DV) was 0.95 ± 0.67 D. The astigmatism correction index (CA/TA) was 0.70, and the index of success (DV/TA) was 0.54. The astigmatism correction index was not near the ideal of 1, and the index of success was far from the ideal of 0 (Table [3](#Tab3){ref-type="table"}).

In other study of normal corneal patients, the astigmatism correction index was 0.95, but the index of success was 0.44 after toric IOLs implantation \[[@CR16]\].

We hypothesized that this inaccuracy of correction compared to normal patients occurs because of the undercorrection of total corneal astigmatism, irregular corneal surface, and corneal opacity covering central pupillary area.

Despite of inaccurate correction of astigmatism in patients with opacity covering large part of covering pupil, the visual acuity was improved (in the size of opacity covering pupil 2 mm, 0.2 logMAR of uncorrected visual acuity and 0.3 logMAR of best corrected visual acuity in Fig. [7](#Fig7){ref-type="fig"}).

Therefore, we think it is worthy of implantation toric IOLs in patients with corneal opacity, despite of relatively inaccurate correction compared to normal patients with clear cornea.

This was the first study to evaluate toric IOL implantation outcomes in cataract patients with corneal opacity. The postoperative visual acuity was significantly improved in spite of the previously existing corneal opacity. The postoperative residual refractive astigmatism was also significantly improved. Postoperative UCVA and BCVA were correlated with the percentage of corneal opacity covering pupillary area. Therefore, toric IOL implantation is effective for improving visual acuity in patients with corneal opacity and cataract.

The short duration of follow up (2 month) and lack of control over the monofocal IOL of the subjects were among the limitations of this study. A multicenter clinical trial with a larger sample size and longer follow up period is suggested to observe the long-term efficacy of the toric intraocular lens implantation in cataract patients with corneal opacity.

Conclusions {#Sec10}
===========

Toric intraocular lens implantation can improve visual acuity and refractive astigmatism in cataract patient with corneal opacity. The percentage of central corneal opacity covering pupillary area is the major prognostic factor for postoperative visual improvement. Therefore, toric intraocular lens implantation should be considered for cataract patients who have corneal opacity with regular astigmatism.

BCVA

:   Best corrected visual acuity

LogMAR

:   Logarithm of the Minimum Angle of Resolution

TIOL

:   Toric intraocular lens

UCVA

:   Uncorrected visual acuity
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